What's breaking now, across thousands of outlets.
The FDA is looking into a “serious risk” of cancer linked to Novartis’ spinal muscular atrophy gene therapy Zolgensma, the agency said Friday. It follows Novartis' disclosure Thursday ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Captain Dewi Lake knows there is plenty to improve following a lacklustre 28-21 Nations Championship victory over Japan.
Ebola has been known about for decades, but there is still no vaccine against the Bundibugyo strain of the virus causing the current outbreak.
Ebola has been known about for decades, but there is still no vaccine against the Bundibugyo strain of the virus causing the current outbreak.
Researchers found that the stroke incidence rate among adults from 1993-94 nearly doubled in 2020, jumping from 33.90 cases per 100,000 people to 62.18 cases.
Everyone is talking about the GLP-1 battle between Eli Lilly and Novo Nordisk, but Pfizer wants in on the fight, too.
LAHORE: The Lahore administration’s polio teams administered drops to 2,153,020 children across the provincial metropolis during the first five days of the campaign and reached 1,499,695 households…
